Literature DB >> 9712744

Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells.

I Peiffer1, A L Servin, M F Bernet-Camard.   

Abstract

Diffusely adhering Escherichia coli (DAEC) C1845 (clinical isolate) harboring the fimbrial adhesin F1845 can infect cultured human differentiated intestinal epithelial cells; this process is followed by the disassembly of the actin network in the apical domain. The aim of this study was to examine the mechanism by which DAEC C1845 promotes F-actin rearrangements. For this purpose, we used a human embryonic intestinal cell line (INT407) expressing the membrane-associated glycosylphosphatidylinositol (GPI) protein-anchored decay-accelerating factor (DAF), the receptor of the F1845 adhesin. We show here that infection of INT407 cells by DAEC C1845 can provoke dramatic F-actin rearrangements without cell entry. Clustering of phosphotyrosines was observed, revealing that the DAEC C1845-DAF interaction involves the recruitment of signal transduction molecules. A pharmacological approach with a subset of inhibitors of signal transduction molecules was used to identify the cascade of signal transduction molecules that are coupled to the DAF, that are activated upon infection, and that promote the F-actin rearrangements. DAEC C1845-induced F-actin rearrangements can be blocked dose dependently by protein tyrosine kinase, phospholipase Cgamma, phosphatidylinositol 3-kinase, protein kinase C, and Ca2+ inhibitors. F-actin rearrangements and blocking by inhibitors were observed after infection of the cells with two E. coli recombinants carrying the plasmids containing the fimbrial adhesin F1845 or the fimbrial hemagglutinin Dr, belonging to the same family of adhesins. These findings show that the DAEC Dr family of pathogens promotes alterations in the intestinal cell cytoskeleton by piracy of the DAF-GPI signal cascade without bacterial cell entry.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712744      PMCID: PMC108482          DOI: 10.1128/IAI.66.9.4036-4042.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells.

Authors:  M F Bernet-Camard; M H Coconnier; S Hudault; A L Servin
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

2.  Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines.

Authors:  M F Bernet-Camard; M H Coconnier; S Hudault; A L Servin
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

3.  Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1.

Authors:  A M Shenoy-Scaria; J Kwong; T Fujita; M W Olszowy; A S Shaw; D M Lublin
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

4.  Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells.

Authors:  H Yano; S Nakanishi; K Kimura; N Hanai; Y Saitoh; Y Fukui; Y Nonomura; Y Matsuda
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

5.  Human cultured intestinal cells express attachment sites for uropathogenic Escherichia coli bearing adhesins of the Dr adhesin family.

Authors:  S Kernéis; J M Gabastou; M F Bernet-Camard; M H Coconnier; B J Nowicki; A L Servin
Journal:  FEMS Microbiol Lett       Date:  1994-06-01       Impact factor: 2.742

6.  Decay-accelerating factor functions as a signal transducing molecule for human T cells.

Authors:  L S Davis; S S Patel; J P Atkinson; P E Lipsky
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

Review 7.  Structure and function of decay accelerating factor CD55.

Authors:  A Nicholson-Weller; C E Wang
Journal:  J Lab Clin Med       Date:  1994-04

8.  Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling.

Authors:  K Kotani; K Yonezawa; K Hara; H Ueda; Y Kitamura; H Sakaue; A Ando; A Chavanieu; B Calas; F Grigorescu
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

9.  Tyrosine phosphorylation is involved in reorganization of the actin cytoskeleton in response to serum or LPA stimulation.

Authors:  M Chrzanowska-Wodnicka; K Burridge
Journal:  J Cell Sci       Date:  1994-12       Impact factor: 5.285

10.  Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction.

Authors:  B Nowicki; A Hart; K E Coyne; D M Lublin; S Nowicki
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  30 in total

1.  Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules.

Authors:  J Guignot; M F Bernet-Camard; C Poüs; L Plançon; C Le Bouguenec; A L Servin
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Pyelonephritogenic diffusely adhering Escherichia coli EC7372 harboring Dr-II adhesin carries classical uropathogenic virulence genes and promotes cell lysis and apoptosis in polarized epithelial caco-2/TC7 cells.

Authors:  J Guignot; J Breard; M F Bernet-Camard; I Peiffer; B J Nowicki; A L Servin; A B Blanc-Potard
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains.

Authors:  Patrick Brest; Frédéric Bétis; Nicolas Cuburu; Eric Selva; Magali Herrant; Alain Servin; Patrick Auberger; Paul Hofman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 4.  Adherence of diarrheagenic Escherichia coli strains to epithelial cells.

Authors:  Alfredo G Torres; Xin Zhou; James B Kaper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 5.  Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells.

Authors:  P Goluszko; B Nowicki
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Pathogenesis of leptospirosis: interaction of Leptospira interrogans with in vitro cultured mammalian cells.

Authors:  Yunying Liu; Wei Zheng; Liwei Li; Yafei Mao; Jie Yan
Journal:  Med Microbiol Immunol       Date:  2007-04-12       Impact factor: 3.402

7.  Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli.

Authors:  John K Crane; Irina Shulgina; Tonniele M Naeher
Journal:  Purinergic Signal       Date:  2007-05-17       Impact factor: 3.765

8.  Structural and functional lesions in brush border of human polarized intestinal Caco-2/TC7 cells infected by members of the Afa/Dr diffusely adhering family of Escherichia coli.

Authors:  I Peiffer; J Guignot; A Barbat; C Carnoy; S L Moseley; B J Nowicki; A L Servin; M F Bernet-Camard
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55.

Authors:  Sylvie Hudault; O Brad Spiller; B Paul Morgan; Alain L Servin
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.